Tickers

1. Composite Trajectory Verdict

Given BBWI’s capital-intensive retail model with significant fixed lease obligations and debt, the income statement and cash flow statement carry the most weight for assessing financial performance, as they reflect the core profitability and liquidity generation that service the balance sheet structure.

Composite Trajectory: Mixed

The annual income statement shows a clear deteriorating trend over three fiscal years, with net sales, operating income, and net income all declining and margins compressing. Conversely, annual operating cash flow and free cash flow have improved markedly. The most recent quarterly (Q2 FY2026) and year-to-date GAAP results show improving profitability and cash generation, but these are heavily influenced by one-time items including ~$80 million of IEEPA tariff refunds, an $88 million interchange fee settlement gain, and a $62 million tax benefit. The balance sheet shows debt reduction in 2026 and a narrowing equity deficit, yet the non-GAAP leverage ratio increased in FY2025 due to lower EBITDAR. Thus, the annual earnings trajectory is deteriorating, cash flow trajectory is improving, and the balance sheet trajectory is mixed.

2. Red Flags

• Annual operating income declined 11% YoY in FY2025 to $1,126 million from $1,266 million in FY2024, and has fallen each year from $1,285 million in FY2023 (10-K 2026-01-31, Consolidated Statements of Operations).
• Annual net income dropped 19% YoY in FY2025 to $649 million from $798 million in FY2024, down from $878 million in FY2023 (10-K 2026-01-31, Consolidated Statements of Operations).
• Gross margin compressed to 43.7% in FY2025 from 44.3% in FY2024, driven by tariff impacts (10-K 2026-01-31, MD&A).
• Non-GAAP debt leverage ratio increased to 2.7x at January 31, 2026 from 2.5x at February 1, 2025, as EBITDAR fell to $1,847 million from $1,966 million while adjusted debt remained flat at ~$4.95 billion (10-K 2026-01-31, MD&A, Debt Leverage Ratio table).
• Q2 FY2026 operating income growth of 37% ($216 million vs $157 million) was primarily driven by approximately $80 million of IEEPA tariff refunds (10-Q 2026-08-01, MD&A, Gross Profit).
• YTD FY2026 operating cash flow of $316 million includes $88 million from interchange fee settlements, $85 million from IEEPA tariff refunds and interest, and a $62 million tax benefit from resolved tax matters (10-Q 2026-08-01, Consolidated Statements of Cash Flows).
• Shareholders’ equity remains deeply negative at -$1,279 million at FY2025 year-end, though improved from -$1,383 million a year prior (10-K 2026-01-31, Consolidated Balance Sheets).
• The 6.694% Senior Notes due January 2027 ($280 million) were classified as current debt at FY2025 year-end and subsequently redeemed in Q1 FY2026 at a $9 million pre-tax loss (10-K 2026-01-31, Subsequent Events; 10-Q 2026-08-01, Long-term Debt).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: On an annual basis, GAAP earnings have deteriorated over three years: net sales declined 0.2% in FY2025 to $7,291 million from $7,307 million in FY2024 (and from $7,429 million in FY2023); operating income fell 11% to $1,126 million from $1,266 million, with operating margin contracting to 15.4% from 17.3%; net income fell 19% to $649 million from $798 million (10-K 2026-01-31, Consolidated Statements of Operations). However, the most recent quarterly period shows improvement: Q2 FY2026 net sales decreased 2.3% to $1,514 million, but operating income rose 37% to $216 million (margin 14.2% vs 10.2%), and net income increased to $118 million from $64 million (10-Q 2026-08-01, Consolidated Statements of Operations). Year-to-date FY2026 operating income rose 22% to $447 million from $367 million (margin 15.4% vs 12.3%). The quarterly improvement is largely attributable to ~$80 million of IEEPA tariff refunds boosting gross margin and an $88 million interchange fee settlement gain reducing expenses (10-Q 2026-08-01, MD&A and Adjusted Financial Information).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Overall Assessment: Annual operating cash flow has risen consecutively: $1,102 million in FY2025, up from $886 million in FY2024 and $954 million in FY2023 (10-K 2026-01-31, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow less capital expenditures) increased to $865 million in FY2025 from $660 million in FY2024 (10-K 2026-01-31, MD&A). Year-to-date FY2026 operating cash flow reached $316 million versus $145 million in YTD FY2025 (10-Q 2026-08-01, Consolidated Statements of Cash Flows). Capital expenditures have been stable at $237 million in FY2025 vs $226 million in FY2024 (10-K 2026-01-31). The cash improvement reflects working capital benefits, particularly a $111 million increase in accounts payable and accrued expenses in FY2025 (10-K 2026-01-31, MD&A), though YTD FY2026 includes significant one-time cash inflows from tariff refunds, litigation settlements, and a tax benefit (10-Q 2026-08-01, Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total debt was essentially flat at $3,892 million at January 31, 2026 versus $3,884 million at February 1, 2025 (10-K 2026-01-31, Consolidated Balance Sheets). Cash and equivalents increased to $953 million from $674 million over the same period (10-K 2026-01-31). The shareholders’ deficit narrowed to -$1,279 million from -$1,383 million (10-K 2026-01-31). However, the company’s non-GAAP debt leverage ratio rose to 2.7x from 2.5x due to lower EBITDAR (10-K 2026-01-31, MD&A). In the first half of FY2026, total debt decreased to $3,614 million at August 1, 2026 following redemption of the 2027 notes (10-Q 2026-08-01, Long-term Debt), cash declined seasonally to $794 million, and the equity deficit improved further to -$1,054 million (10-Q 2026-08-01, Consolidated Balance Sheets). Current debt of $248 million at August 1, 2026 reflects the subsequent partial redemption of the 2029 notes (10-Q 2026-08-01).

6. Data Gaps

• Full quarterly income statements for Q1 FY2026, Q3 FY2025, and Q4 FY2025 to assess sequential quarterly trends (only Q2 FY2026 and YTD provided in 10-Q 2026-08-01).
• FY2026 full-year actual results versus the outlook provided in the 10-K (only outlook narrative available).
• Detailed breakdown of “Business Transformation Activities” costs beyond the $15 million in FY2025 and $9 million in Q2 FY2026 (10-K 2026-01-31 and 10-Q 2026-08-01).
• Comparable store sales metrics for recent quarters (only annual sales per square foot disclosed in 10-K).
• FY2023 cash flow statement details (only summary figures in 10-K).
• Quantified impact of the supplier finance program on accounts payable and operating cash flow (mentioned in 10-K Note 1 but not isolated in cash flow statement).